Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Eliem Therapeutics Inc | ELYM | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
7.70 | 7.56 | 8.30 | 7.71 | 7.66 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
17/5/2024 | 15:36 | EDGAR2 | Form PREM14A - Preliminary proxy statements relating to.. |
17/5/2024 | 15:01 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
15/5/2024 | 05:19 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
07/5/2024 | 17:01 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
11/4/2024 | 15:27 | PRNUS | Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to.. |
11/4/2024 | 06:00 | GLOBE | Eliem Therapeutics Announces Agreement to Acquire Tenet.. |
04/3/2024 | 10:07 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14/11/2023 | 15:01 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/11/2023 | 16:13 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
10/8/2023 | 15:06 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
20/7/2023 | 05:55 | EDGAR2 | Form 8-K - Current report |
20/7/2023 | 05:45 | GLOBE | Eliem Therapeutics Announces Plans to Explore Strategic.. |